Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge Golimumab, ATC L04AB06
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Golimumab, ATC L04AB06”. Bids close on 5 February 2027.
The work
Non-exclusive discount agreements for Golimumab (ATC L04AB06) for AOK Bayern from 01.04.2025 to 31.03.2027.
- Identical and non-negotiable discount agreements
- Contract can be terminated with one month's notice at month-end
- Agreement is nullified by a national or state-level discount contract for the same active substance
Key facts
- Contract period
- 01.04.2025 to 31.03.2027
- Evaluation
- Selection is based on the submission of a signed Eigenerklärung zur Zuverlässigkeit.
What it takes to qualify
Worth a closer look
- The text is a mix of German and English, and the process is an 'open-house' model, not a standard tender. The term 'Arzneimittelrabattverträge' (drug discount agreements) is specific to the German healthcare system and may not have a direct equivalent in a standard tender schema.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zur Zuverlässigkeitsigned declaration of reliability
- Vertragfilled and signed contract
- Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"filled and signed list of contract drugs
- Handelsregisterauszugextract from trade register to show signatory authority
- Vollmachtpower of attorney if signatory authority not from trade register